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Abstract
Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), remains a debilitating
disease that affects the health of millions annually. Understanding its ability to persist within
host and resist eradication by antibiotics is of utmost importance in the effort to develop new
interventions. This study will focus on the transcriptional activator WhiB7 and its regulation of
the multidrug Tap efflux pump encoded by Rv1258c. WhiB7 is thought to respond to redox
stress induced by antibiotics and a variety of in vivo stresses by activating multiple genes
including Rv1258c. Much remains to be determined regarding the role of WhiB7 and
downstream genes in Mtb virulence and drug resistance. We will create a tool for studying
WhiB7-mediated gene regulation by engineering a strain of the nonpathogenic bacterium Msm
expressing the mCherry fluorescent protein controlled by the Rv1258c promoter. Knocking out
the native WhiB7 gene in Msm via homologous recombination will allow clear introduction of
wild type and mutant versions of Mtb WhiB7. Changes in the fluorescent activity of Rv1258c
promoter fusion to mCherry will indicate the effects of WhiB7 mutagenesis. Secondly, we can
also use this system to confirm additional genes identified by microarray analysis that are
potentially regulated by WhiB7. This will be done by cloning other promoters in front of
mCherry in the Msm strain containing wild-type Mtb WhiB7. Understanding WhiB7’s role in
Mycobacterium tuberculosis macrophage survival and antibiotic resistance may provide new
strategies for developing drugs that can lead to a cure.
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Introduction
Mycobacterium tuberculosis (Mtb), the etiologic agent of tuberculosis, remains a
debilitating disease that affects the health of millions annually. Mtb is transmitted in airborne
droplets from one infected individual to another where it will reside in characteristic lesions
known as granulomas within pulmonary tissue. The mycobacteria bacilli survive in granulomas
formed by the host white blood cells, primarily macrophages and T lymphocytes. In the case of
active infection, the body’s immune system fails to contain the bacilli within granulomas,
resulting in pulmonary damage and spread to other tissues within the body leading to systemic
impairment or death [1]. Treatment of tuberculosis requires a cocktail of four drugs taken over
the course of six to nine months. Tuberculosis is particularly difficult to treat due to the nature
of its intrinsic resistance mechanisms such as its cell wall structure [2]. Mtb has a
characteristically thick mycolic acid-containing cell wall which makes it resistant to antibiotic
penetration [3]. Additionally, Mtb regulates inducible efflux pumps and activates enzymes that
assist in making it resistant to antibiotics and persist within macrophage [4]. The emergence of
Multi-Drug Resistant (MDR) and Extremely Drug Resistant (XDR) strains of Mtb further
complicates the problem [3]. Understanding Mtb’s ability to persist within immune cells and
pulmonary tissue and resist eradication by antibiotics is of utmost importance in the effort to
develop new drug interventions.
This study will focus on the transcriptional activator WhiB7 and its regulation of the
multidrug Tap efflux pump encoded by Rv1258c. WhiB7 is thought to respond to redox stress
induced by antibiotics and a variety of in vivo stresses by activating multiple genes including
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Rv1258c. Much remains to be determined regarding the role of WhiB7 and downstream genes
in Mtb virulence and drug resistance. We will create a tool for studying WhiB7-mediated gene
regulation by engineering a strain of the nonpathogenic bacterium M. smegmatis (Msm)
expressing the mCherry fluorescent protein controlled by the Rv1258c promoter. Knocking out
the native WhiB7 gene in Msm (WhiB7Msm) via homologous recombination will allow clear
introduction of wild type and mutant versions of Mtb WhiB7 (WhiB7Mtb). Changes in the
fluorescent activity of Rv1258c promoter fusion to mCherry will indicate the effects of WhiB7
mutagenesis. Secondly, we can also use this system to confirm additional genes identified by
microarray analysis that are potentially regulated by WhiB7. This will be done by cloning other
promoters in front of mCherry in the Msm strain containing wild-type WhiB7Mtb. Understanding
WhiB7’s role in Mtb macrophage survival and antibiotic resistance may provide new strategies
for developing drugs that can lead to a cure.

2

Chapter One: Tuberculosis: The Global Killer
Introduction
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), continues to be
prevalent in today’s society. Dating back to 1882, microbiologist Dr. Robert Koch was the first to
characterize the tuberculosis infection as caused by Mycobacterium tuberculosis (Mtb). In 1882,
tuberculosis was said to take the life of one out of seven individuals in the United States and
Europe alone. In present day, we have seen this number greatly reduced, although there are
still nine million new cases and 1.3 million deaths due to TB each year. This problem is
exacerbated by the emergence of multidrug-resistant (MDR) strains [1]. 95% of infected
individuals are in developing countries. Tuberculosis, which infects all ages, is the second
greatest killer of individuals caused by a single infectious agent worldwide, second to HIV/AIDS
[2]. HIV co-infection with TB kills one out of five HIV patients annually. It is important for us to
be able to understand the microbiological components found in Mtb and how and why this
disease still persists in today’s society. The purpose of this section is to provide relevant
background information on this bacterial pathogen, its antibiotic resistance mechanisms, and
provide relevant innate immunological information about the pathophysiological response to
tuberculosis.
Who is at risk?
There are multiple factors that increase the risk of individuals contracting tuberculosis.
Persons at particular risk are individuals with a re-activation of poorly treated infections,
persons who illicit drugs, and persons with human immunodeficiency virus (HIV). People
coinfected with HIV-TB have the worst prognosis than any of the other listed populations [3].
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HIV is a retrovirus that brings on immunodeficiency, which makes individuals more susceptible
to opportunistic infections such as tuberculosis. 12% of HIV patients die as a result of
tuberculosis infection [4]. When an individual with HIV is exposed to active tuberculosis,
tuberculosis infection is harder to diagnosis with sputum smear microscopy, and is more likely
to reactivate [5]. Co-infected individuals are treated using antiretroviral therapy, ART. ART is a
treatment plan designed to suppress the HIV virus. When HIV patients are given treatment for
tuberculosis while starting ART, pharmacokinetic interactions with rifamycins tend to occur.
Thus, treatment for HIV patients co-infected with tuberculosis tend to raise the mortality rate
of infected persons [6].
Vaccines
The tuberculosis vaccine is available to individuals at risk for incidence of infection. The
available vaccine called Bacillus Calmette-Guérin, BCG, is a live attenuated bovine strain of
tuberculosis (M. bovis). The vaccine is usually given to children who are consistently exposed to
parental caregivers with tuberculosis, or are at risk of exposure due to geographic factors.
Immunizations are also given to healthcare providers that are at risk of occupational exposure
[7]. Risk factors prompting immunization include occupational exposure to Mtb, high frequency
of hospital acquired infections, and poor facility infection control.
Immunocompromised individuals are not provided with the vaccine due to subsequent
opportunistic infection that may be possible if given. Pregnant women are omitted from
vaccination as precaution. Specifically in developed countries, the vaccine is not administered
to the general population; if given, it will give false positive results for the tuberculin purified
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protein derivative (PPD) skin test. Although, success of the current BCG vaccine is limited:
approximately 0-80% of the individuals that receive the vaccine are resistant to the lifethreatening miliary and meningeal infections [7].
Diagnostics
Currently the most common method of diagnosis is the acid-fast sputum smear. In this
method, a sputum sample taken from suspected patients is stained and examined through
microscopy for the presence of acid-fast bacilli. This procedure is only able to identify
approximately 50% of infections. Bacterial culture and identification is the gold standard to
positively identify TB. However useful, this is a dangerous and slow method given the
hazardous and slow-growing characteristics of Mtb. NAAT (nucleic acid amplification tests) or
polymerase chain reaction based methods are more sensitive and specific, but are underutilized
because they are expensive and not feasible in resource limited settings.
Patients suspect for tuberculosis infection, active or latent, are given a PPD skin test.
The PPD is an extract from Mtb and is injected into patient’s skin intradermally. When the body
has been previously exposed to Mtb antigens, such as in an infected or vaccinated state, local
inflammation at the site of injection will occur due to the innate immunological response to the
foreign agent. The response to the antigen can be detected on the skin by studying the radius
of inflammation. If the skin test is positive, the individual will be then given a chest x-ray to
determine if the individual has an active, or latent form of tuberculosis. Post-diagnosis, the
patient will start on a rigorous antibiotic regimen for up to twelve months depending on the
severity of the infection.
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Treatment
Currently there are two treatment plans to cure tuberculosis which is determined by the
strain of Mtb that has caused the infection. Treatment of active drug-sensitive tuberculosis
involves the use of antibiotics such as isoniazid, rifampin (or rifapentine), ethambutal, and
pyrazinamide over the course of six to twelve months. Treatment of multidrug-resistant
tuberculosis infection (MDR TB), and extensively-drug resistant tuberculosis infection (XDR TB)
is more complex. Treatment of XDR and MDR strains is difficult because these strains are
resistant to the frontline drugs, rifampicin and isoniazid, and some second-line drugs in the case
of XDR TB. The second line fluoroquinolone and injectable drugs are then utilized for MDR, and
XDR strains [1, 8]. In most cases, the drugs are unable to permeate the granulomas in the lung,
or Mtb has become inherently phenotypically drug tolerant. Additionally, due to the harshness
of the antibiotics on the system, patient compliance is reduced. Treatment of MDR and XDR
strains of Mtb have adverse effects on the health of the patient; this results in six out of ten
infected patients dying at the same rate as an infected individual not taking the treatment [9].
Due to the structural and resistant nature of Mycobacterium tuberculosis, new drug targets
need to be identified if we hope to eradicate this pathogen.
Microbiologic characteristics of Mycobacterium tuberculosis
Mycobacteriaceae is a non-endospore forming, acid-fast positive organism, which
means the bacterium contains a thick peptidoglycan and mycolic wax layer in the outermost
leaflet of the cell wall. Mycobacterium is a non-motile family of organisms dependent on the
presence of oxygen for growth and production of energy. They have an unusually high content
of guanine and cytosine, over 60%, in their deoxyribonucleic acid, DNA. This study focuses on
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the most deadly pathogenic member of this genus, Mycobacterium tuberculosis. Mtb is known
for its very slow growth rate, structural tolerance to their environment, and mechanisms that
inhibit the antimicrobial response of macrophages.
The peptidoglycan layer of this acid-fast bacterium is capable of making the organism
structurally resistant to osmotic lysis. This structure is a polymer of sugars N-acetylglucosamine
and N-acetylmuramic acid and amino acids such as L-alanine, D-alanine, D-glutamic acid and
diaminopimelic acid. The peptidoglycan layer is formed by a chain of sugars that run parallel to
each other while forming amino acid cross-links that acts as an interbridge between sugar
chains. The rigidity of this cell wall is able of providing the organism with the resistance to
external aqueous environments, where gram-negative organisms might have susceptibility to
these influences; thus aiding in the transmission of Mtb through liquid droplets.
Targeting the peptidoglycan layer with drugs is a traditional way to treat diseases
caused by gram-negative bacteria. Antibiotics such as penicillin block the formation of the Nacetylglucosamine and N-acetylmuramic acid bonds, leaving the bacterium susceptible to
eventual osmotic lysis [10]. But targeting this structure in Mtb is ineffective due to the presence
of the mycolic acid layer.
In addition to the peptidoglycan, the cell wall of Mtb has a lipid-wax complex that
provides additional resistance to environmental and antibiotic stress. Mycolic acids are the
outer most surface of the mycobacterial cell wall. This layer is a complex of hydroxylated lipids
that provide a lipophilic surface covalently bound to the cell wall. This mycolic wax surface
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reduces permeability to antibiotics which narrows the spectrum that is available to target and
treat the bacteria.
Mycolic acid is a primary contributor to the cell wall’s resistance to the degrading
activity of the macrophage’s cationic, lysozyme and oxygen radical activity. Additionally, the
cord factor component of Mtb’s cell wall is toxic to mammalian cells and is abundant in virulent
strains of Mtb [11, 12]. Cord factor is an inhibitor of polymorphonuclear leukocyte migration
and fusion with infected macrophages, thus slowing the activity of the granuloma [12].
Granulomas are formed in response to the presence of Mtb in the lung, and will be discussed in
subsequent sections.
Transmission
The transmission of Mtb is a topic of heightened concern. Tuberculosis is spread in
liquid droplets contained inside what is referred to as droplet nuclei. Droplet nuclei are small
micro-droplets about the size of a micrometer that can contain an infectious agent, in this case
Mtb, which can be maintained in the air for hours. These droplet nuclei carry the infectious
agent from one host to another through expulsion from the infected pulmonary or laryngeal
tissue by means of sneezing, coughing or talking [13]. The Mtb droplet nuclei are taken into the
lungs, and dispersed throughout the lung tissue in various places. After inhalation of infected
droplets by a non-infected host, infection is determined by the strength of the host’s immune
system, number of the bacilli in the droplet, and the exposure of the bacterium to UV light [14,
15]. If a bacterial presence can be maintained inside the pulmonary tissue of the host, there is
an increased likelihood the bacillus can be transmitted to other tissues through the lymphatic

8

and circulatory systems. Systemic impairment and death will occur if the infection is not
contained before spreading. The subsequent section will explain the pathophysiology of the
initial immunological response to foreign agents as it relates to tuberculosis infection.
Innate immunology: Macrophage Infection
It is imperative in this study to understand the natural immunological response
mediated by macrophages in order to understand the pathophysiology of a tuberculosis
infection. This section will cover the basic immunological response to an infectious agent in the
lungs, then follow with a section that relates specifically to tuberculosis infection.
During inhalation, an infectious agent will first encounter physical barriers of the innate
immune system, the non-specific first line of defense. Initially the infectious agent is exposed to
the pseudostratified ciliated columnar epithelium which lines the trachea. This type of
epithelium is responsible for the secretion of mucus, composed of glycosylated proteins that
function to trap foreign particles, and utilizing its characteristic cilia to move the secreted
mucus in a particular direction. In the case of the trachea, the objective of this mucociliary
escalator is to push trapped particle upward to the mouth for expulsion. This is an effective
system of physical immune barriers that is able to rid the body of most airborne and ingested
contaminants [16]. If the liquid droplet can bypass the mucus physical barrier, the agent will
travel down the lung and into the airways of the lung. Typically, the sight of initial infection is
found in airways such as the alveoli of the luing. These small air pockets are lined with
squamous epithelium that are the sight of the next immunologic agent in the sequence, called
the macrophage [14, 16].
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Macrophages are the are key players in the innate immune response, serving as a front
line of defense against pathogens [17]. Macrophage are professional phagocytes capable of
ingesting and destroying most pathogens and initiating and coordinating an adaptive immune
response. Macrophages recognize and phagocytose foreign bodies by binding to specific sites
called pathogen-associated molecular patterns (PAMPs).

These patterns are traditionally

specific structures (i.e. surface proteins or carbohydrates) of a pathogen that bind to a specific
pattern recognition receptor (PRR). For example: a macrophage will recognize the
lipoarabinomannan glycolipid located in Mtb’s cell wall, the PAMP in this case, and bind to its
PRR. Once the macrophage recognizes the PAMP on the foreign agent the cell membrane will
extend and engulf the phagosome creating a phagosome[18].
Infected macrophages release hydrolytic enzymes, cationic proteins and oxygen radicals
from lysosomes. These degradative agents are released into the phagosome after the
macrophage’s lysosome fuses with the vesicle containing the engulfed bacterium, forming a
phagolysosome [12]. Following phagocytosis of a pathogen, macrophages will initiate the
body’s immunologic response by releasing cytokines such as monocyte chemoattractant
proteins to attract other macrophages and leukocytes to the site of infection [19]. After
signaling the immunologic response, the infected alveolar macrophage becomes surrounded by
mononuclear cells in an attempt to sequester any foreign agent from the rest of the
surrounding pulmonary tissue. This complex of non-infected macrophages and infected
macrophages is the containment structure of the immune system called the granuloma. After
the formation of the granuloma, the bacterial components are degraded and utilized or
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exocytosed for removal from the tissue. In the case of most bacteriological infectious agents,
this disposal method is sufficient to maintain homeostasis, and allows the body to be innately
resistant to foreign agents.
In the case of tuberculosis, the innate immune response may be unable to completely
eradicate this infectious agent. Failure to kill all Mtb is due to TB’s system of resistance to
external stresses which allow the bacterium to survive when exposed to host-derived
antimicrobial mechanisms. In 9 out of 10 infections, the immune response successfully controls
the infection, forcing the pathogen into a latent stage. In the latent stage, the bacterium will
not grow, but will persist inside the pulmonary system without harming the host until the host
becomes immunocompromised. If the granuloma’s structural integrity is compromised in an
immunocompromised host, the sequestered Mtb will become active, replicate, and spread [20].
If the active stage of infection is not treated successfully, the infection may lead to
systemic failure and death. Active tuberculosis can disseminate to other parts of the body
through the bloodstream or lymphatic system. Once active tuberculosis has entered the
circulatory system it is said to be in the milliary stage of infection. In this stage lesions, also
referred to as granulomas, can start to appear all over the body impairing host function. In the
advanced stages of infection, these tubercles for unknown reasons liquefy and spread to other
regions of the body, infecting the host on a greater scale. In the case of a severe infection, the
bacillus will reach the nervous system leading to tubercular meningitis, which will result in
death if left untreated [20].
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Mtb’s Survival in the Macrophage
Inside of a macrophage Mtb is exposed to a variety of stressors that influence its growth
and development. Stressors include acidification and hypoxic stress, iron starvation, nutrient
deprivation, and other environmental cues such as reactive nitrogen and oxygen species.
Sensing and survival of stresses is imperative for Mtb’s sustained presence inside of a
macrophage. In addition to the structural components outlined in Mtb microbial section, efflux
pumps, and gene expression regulators are utilized by Mtb to combat macrophages.
There may be many ways in which Mtb is able to sense its environment. One is the
utilization of two component systems (TCS) that consist of a receptor, usually on the cell
membrane, and an effector that activates downstream genes. One such example is the PhoPPhoR system. Activation of PhoP-PhoR system is what is primarily responsible for responding to
changes in metabolic and respiration regulation [21]. Mtb is equipped with over a hundred
stand-alone transcription factors that modulate gene expression.
Changes in the redox state of the cytoplasm can occur when the phagosome containing
Mtb fuses with the lysosome to expose it to acidifying agents, or when changes in nutrient
metabolism causes the production of harmful waste products. Responding to theses stressors is
done in part by regulation of efflux pumps. Efflux pumps are membrane bound transmembrane
transport proteins that are stress induced pumps designed to transport potentially harmful
substances out of the bacterial cell [22]. For example, the activity of the efflux pump allows Mtb
to inhibit the fusion of lysosome with the phagosome through Mtb’s secretion of potassium
through a potassium proton efflux antiport that alters maturation of the phagosome-lysosome
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complex [23]. Mtb must combat these influences by regulating downstream genes in times of
stress
Efflux pumps also play a significant role in drug resistance by providing the ability to
pump drugs out of the bacterial cytoplasm. It is the activity of these transporters that is
responsible for multidrug resistance strains of bacteria, including Mtb. Understanding the role
of efflux pumps, and the regulation of such in times of macrophage survival may lead to new
strategies to develop drugs that can lead to a cure.

13

Chapter Two: Transcriptional Regulator WhiB7
Introduction
An essential aspect of microbial pathogenesis is the ability of pathogens to carefully
regulate the expression of virulence factors during infection in response to host-derived cues.
Virulence factors may include a wide variety of components such as structural, genetic and
enzymatic activity that provides the infectious agent with a proclivity to cause disease. The
ability of Mtb to survive within macrophages, remain dormant in granulomas for decades, and
resist antibiotic therapy hinges on its appropriate genetic regulation of virulence mechanisms.
This chapter will focus on the genetic regulation of virulence factors that contribute to Mtb
pathogenesis, with specific emphasis on one particular regulator mechanism that is the basis of
this study.
Regulation of gene expression in bacterial systems
In bacteria, the regulation of gene expression primarily occurs at the level of
transcription. Thus, increasing or decreasing the production of a specific gene product occurs
by controlling the level of mRNA transcripts produced. This is accomplished by regulatory
proteins known as transcription factors (TF) which sense and respond to environmental cues by
binding to promoter regions of specific genes. Knowing how bacteria regulate virulent gene
expression will increase our understanding of Mtb’s pathogenesis and subsequent disease.
In normal biological systems organisms must make messenger ribonucleic acid, mRNA,
from deoxyribonucleic acid, DNA, in order to form long peptide chains that may fold to form a
protein. In prokaryotes, such as Mtb, gene expression is carried out by the use of a single RNA
polymerase that binds to DNA through the use of a sigma factor that acts as a transcription
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initiation factor. Binding of the sigma factor to a specific promoter recruits RNA polymerase to
initiate mRNA transcript synthesis. The resulting mRNA is then translated by a ribosome to
synthesize a protein product [10]. Some proteins are then able to regulate genes by acting as
repressors and activators.
Regulatory proteins, transcription factors, regulate the transcription of genes in
response to environmental conditions, a process that is crucial for virulence. Transcription
factors are small DNA specific binding factors that regulate the genetic flow of information.
There are two different types of transcription factors, one that inhibits the regulation of a gene
called the repressor, and another factor that promotes the regulation of a gene called the
activator. Transcriptional regulators work to enhance the assembly of the transcription
machinery at promoters by recruiting sigma factors and the RNA polymerase in order to control
transcription [24].
Transcriptional activators are sensing molecules that are able to detect changes to the
status, or environment of the bacterium, and facilitate adaptation to those stresses in order to
survive. Changes in the carbon source, introduction of sub-inhibitory antibiotic concentrations,
heat shock, iron starvation, reductive, and oxidative stress, and hypoxia, causes changes in gene
expression to counter-act these stresses. Therefore it is the principal responsibility of
transcription factors to regulate a particular set of genes in order to maintain homeostasis for
the survival and growth of the organism [25]. The focus of this study is a particular family of
proteins called WhiB proteins, which are identified as transcriptional activators and are
responsible for stress resistance.
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The Role of WhiB proteins
The WhiB family of proteins mostly restricted to a group of filamentous, branching,
gram-positive bacteria called actinomycetes [26]. First identified in Streptomyces coelicolor
mutants, the WhiB genes were shown to have a direct involvement in the formation of spores;
S. coelicolor whiB mutants lost the ability to form spores [27]. Further studies revealed that the
WhiB proteins in Mtb are specifically involved not only in cell division, but also nutrient
starvation, pathogenesis, antibiotic resistance, and stress sensing [28].
The Mtb genome encodes seven different WhiB proteins, each responding in a different
way when exposed to redox signals [28]. WhiB protein sequence analysis shows that all
members of this family contain four conserved cysteine residues and an AT-hook DNA binding
domain. The AT-hook is a DNA binding motif located on the C-terminal end of regulatory
proteins which is consistent with the WhiB family. This region facilitates the formation of the
transcription complex to initiative transcription.
Cysteine residues are significant to the structure of proteins due to their primary
function of holding the tertiary and quaternary structure of proteins together. Cysteine
residues contain a thiol group that link to each other to create a disulfide bridge. These
intramolecular bonds can bind to iron to form an iron sulfur cluster. The iron sulfur cluster is
able detect changes to the oxidative and reductive environment in the cytoplasm [29]. Studies
show that in the time of oxidizing stress, the iron sulfur cluster disintegrates, but in the
presence of reductive environment the iron-sulfur cluster is maintained. The strength and
duration of the redox environment will alter the disulfide bond which will change the
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conformational shape of a protein, therefore changing its function. In summary WhiB proteins
help counteract intracellular changes caused by the enviroment by activating different
downstream genes that play a role in bringing the bacterium back to homeostasis [28].
WhiB7
The function WhiB7 is of particular interest due to its strong correlation with inducible
drug resistance in Mtb, and macrophage survival [30]. Learning how this protein is able to
interact with downstream genes that regulate antibiotic resistance, and resistance to
macrophage stress will allow us to confirm its activity as it relates to Mtb virulence and its
ability to cause disease.
whiB7 is a gene that encodes the WhiB7 transcriptional activator which responds to
changes in the redox environment of the bacterium [30]. The redox balance is changed when
Mtb resides in macrophages and granulomas, a low-oxygen, low-nutrient environment, and
when exposed to antibiotics. Inducible drug resistance is suggested to be regulated by WhiB7
when exposed to antibiotics such as kanamycin, erythromycin, and streptomycin [30]. In times
of macrophage infection stress such as iron starvation, or entrance into the stationary phase,
WhiB7 is significantly upregulated causing activation of downstream genes responsible for
countering the effects of these stressful conditions [31].
Additionally, WhiB7’s activity is upregulated during macrophage infection which is
probably due to nutrient starvation. This occurs when the macrophages phagosome limits the
Mtb’s access to carbon sources, forcing the bacillus to change its carbon source to utilize host
lipids and cholesterol. When metabolized, lipid eating contributes to reductive stress and
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creates harmful byproducts such as propionyl-CoA and its toxic intermediates [31]. Harmful byproducts, like these, may be pumped out of the cytoplasm by efflux pumps. Interestingly, the
WhiB7 transcriptional activator regulating drug resistance, is also responsible for pushing
harmful metabolic waste out of the cell [30].
The whiB7 genetic locus consists of three main regions of importance which we will
address in this study: the whiB7 promoter, a region called MT3290.2, and the whiB7 open
reading frame itself (figure 1). The whiB7 promoter contains the -10 and -35 sigma factor
binding site, as well as an A-T rich region of DNA that acts as a WhiB7 binding site upstream of
the -10 and -35 promoter region. A WhiB7 binding site on the promoter of WhiB7 allows for
positive feedback on the levels of WhiB7. This means the WhiB7 protein has an auto-regulatory
ability, as well as the ability to regulate promoters of downstream genes [32]. This WhiB7
binding site region is conserved throughout the WhiB7 regulon [33]. MT3290.2 is encoded
immediately upstream of whiB7 and is co-transcribed from the same promoter. It is currently
considered as the untranslated region of DNA in between the WhiB7 promoter, and the whiB7
gene itself. This region does not have a known function, but may have activity as non-coding
cis-regulatory elements affecting WhiB7 transcription, or may function as a small regulatory
protein to assist whiB7 regulation. Strains containing a series of mutations in this region cause
an increase in the transcription levels of WhiB7, thus making this region appear to be playing a
role in regulation [33]. The last region in the WhiB7 locus is the whiB7 gene, a 279 base pair
open reading frame encoding conserved features of WhiB proteins including four cysteine
residues and the A-T hook motif.
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There are currently 12 known genes putatively regulated by WhiB7, including three
genes implicated in inducible drug resistance: Rv2416c, Rv1258c, and Rv1988 [30]. These genes
were identified by comparing the microarray expression profiles of a WhiB7 knockout strain, a
WhiB7 overexpressing strain, and parental M. tuberculosis H37Rv. The study showed a strong
correlation between the transcription levels of WhiB7 and the transcription levels of the three
listed genes. Rv2416c, also known as Eis, is an acetyl transferase that modifies kanamycin so
that it can no longer inhibit ribosomal activity [34]. Additionally, in time of macrophage stress
Eis is shown to contribute to enhanced survival of Mtb in macrophages [35]. Rv1988c is
correlated with the resistance to MLS (macrolide, lincosamide, and streptogramin).

The

Rv1258c gene, which is a focus of this study, encodes an efflux pump gene called Tap which
confers resistance to low concentrations of antibiotics [35]. Tap is responsible for Mtb’s
intrinsic resistance to ethambutol, rifampin, and isoniazid, the frontline drugs used in treatment
of tuberculosis. Understanding WhiB7’s role in the regulation of Rv1258 is the emphasis of this
study, in addition to identifying other promoters in the WhiB7 regulon.
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Figure 1: WhiB7-mediated regulation of stress resistance mechanisms
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Chapter Three: Objectives
Objective
It is imperative that we understand the mechanisms that allow Mtb to survive in
macrophages and resist antibiotics. The transcriptional activator WhiB7 has been seen to play a
role in regulating Mtb macrophage survival and drug resistance [30, 36-38]. Our hypothesis is
that WhiB7 is a dual-function regulator involved in macrophage survival and drug resistance
that controls a larger regulon than previously thought. Our aim is to understand mechanisms of
WhiB7-mediated adaptation to these stresses and characterize the role of downstream effector
genes. The focus of this study will be on WhiB7’s ability to regulate a known promoter Rv1258c
which encodes a multidrug efflux pump [30]. We will create a tool for studying WhiB7-mediated
gene regulation by engineering a strain of the nonpathogenic bacterium M. smegmatis
(Msm) expressing the mCherry fluorescent protein controlled by the Rv1258c promoter. Using
Msm as a surrogate for the Mtb WhiB7 circuit will allow us to study the inducers of WhiB7,
essential components necessary for WhiB7 activity, and the activity of WhiB7-regulated
promoters. Studying this gene will provide insight into the activation properties of WhiB7 and
downstream genes in Mtb virulence and drug resistance. Understanding WhiB7’s role
in Mtb macrophage survival and antibiotic resistance may provide new strategies for
developing drugs that can lead to a cure.
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Specific objectives:
To create an Msm surrogate for the study of Mtb WhiB7 gene regulation
We will generate a strain of Msm with its native WhiB7 homologue deleted that will
allow the clear introduction of Mtb WhiB7 without interference from the native Msm WhiB7.
Cloning the Mtb Rv1258c promoter fused to the fluorescent protein mCherry into the Msm
WhiB7 knockout strain will allow us to detect the changes in Rv1258c transcription induced by
WhiB7 mutagenesis described in objective two.
Determine required elements for WhiB7-mediated gene regulation
We will use bioinformatics tools to analyze WhiB7 genomic sequences to identify the
necessary components of the WhiB7 system for DNA binding. A series of altered WhiB7 variants
will be introduced into the WhiB7 knockout strain of nonpathogenic Msm containing the
promoter fusion of Rv1258c and mCherry. Changes in fluorescence will serve as an indicator of
the level of WhiB7 activation.
To confirm genes in WhiB7 regulon
Preliminary microarray analysis of mRNA levels in a WhiB7- mutant and WhiB7
overexpressor vs. wild-type revealed more genes whose expression is affected by the levels of
WhiB7 present. To validate and confirm their control by WhiB7, we will clone the promoter
regions upstream of expressed target genes in front of mCherry. These reporter fusions will be
introduced into our Msm surrogate strain expressing various forms of active or inactive WhiB7
(Figure 2).
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Figure 2: Exploiting M. smegmatis to construct Mtb regulatory circuits. Figure represents a summary of the three main goals of the
project. A) Represents the Msm homologous knockout of whiB7. B) Represents the fluorescent reporter introduced to the chromosome of
Msm used to study WhiB7Mtb. C) Depicts our introduction of mutant and recombinant WhiB7 constructs.
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Chapter Four: Materials and Methods
Introduction
The goal of this study is to understand the molecular mechanisms of WhiB7-mediated
gene regulation in response to antibiotic- and macrophage-derived stresses. Using the methods
previously described, we will make a series of mutant and recombinant versions of Mtb WhiB7
and study their activity using a fluorescent reporter system. The regions of particular interest
when looking at WhiB7 activity involve its promoter, the MT3290.2 gene immediately
upstream, and the WhiB7 gene itself. This gene cassette has the ability to regulate itself and
regulate other downstream promoters in order to maintain Mtb virulence and resistance to
different stresses. This study is designed to understand the WhiB7 cassette. Creating various
forms of this cassette containing engineered mutations and modifications will allow us to
characterize its function. There are a total of four mutant strains that will be created and
studied. Each strain was created using one of two cloning methods, Round the Horn, and
FastCloning.
General Methods
Bacterial Growth and Strain Handling
Two bacterial agents used in this study were Escherichia coli (E. coli) and Mycobacterium
smegmatis strain mc2155 (Msm), E. coli is utilized as a host for plasmid replication during
routine cloning and recombinant DNA procedures. Due to the slow growing and potentially
dangerous aspects of Mtb, Msm was chosen to act as a surrogate in the place of Mtb based on
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their level of genetic similarity. Various mutations and plasmids will be added to the strain of
Msm as described in detail below.
Culture conditions:
E. coli was cultured at 37⁰C in Luria-Bertani (LB) broth shaken at 250 revolutions-perminute (rpm), or on LB agar plates. Msm was cultured at 37⁰C in LB broth containing 0.05%
Tween80, or on LB agar plates.
Transformation conditions for E. coli
Transformation in E. coli was done by using chemically competent cells from New
England Biolabs (NEB). NEB cells were treated with DNA for thirty minutes, heat shocked at
42⁰C for thirty seconds, followed by addition of 250L of SOC (super optimal broth) recovery
media before shaking for two hours at 37⁰C. 150L of this mixture was plated onto selection LB
agar plates.
Electrocompetent cells:
15mL of Msm cultures were pelleted at 4,300 rpm at 4⁰C. Supernatant was removed and
then the pellet was resuspended in one-half of the starting volume of the previous suspension,
using 10% ice-cold glycerol. This process was done four times leaving the final volume at 0.6 mL
left over from the starting volume of 15mL from the overnight culture. 100L of the final
glycerol washed pellet was aliquoted into microcentrifuge tubes. Tubes were then sealed and
treated with dry ice and ethanol to snap-freeze the cells for storage and subsequent
transformation.
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Transformation conditions for Msm:
Transformation of Msm required using electroporation by adding approximately 500ng
of plasmid DNA to 100L of target strain of Msm electrocompetent cells. After 1 minute, cells
were transferred to a 1-mm electroporation cuvette. Cells were pulsed at 2.5kV, 200 Ohms and
25F. 250L of SOC media was then added to electroporation cuvette. Media and
electrocompetent cells were transferred to a sterile tube to be shaken for 2 hours then plated
onto selection LB agar plates.
Vector selection:
Hygromycin (Hyg), streptomycin (Strep), or kanamycin (Kan) was added to liquid and
solid media. For E. coli cultures: Hyg and Kan were used at a final concentration of 50µg/mL in
liquid cultures, and 250µg/mL for Hyg and 50µg/mL for Kan in solid media. For Msm cultures:
Hyg and Kan were used at a final concentration of 50µg/mL in liquid cultures, and for Kan
50µg/mL and streptomycin 100µg/mL in solid media.
FastCloning
Method Overview:
One method that is routinely used in the lab is a DNA cloning method coined as
FastCloning [39]. This FastCloning method is used to clone various fragments into a vector, or,
depending on the vector used, utilized to form gene knockouts. FastCloning allows us to do this
by negating the need to use restriction endonucleases and ligase to make genetic mutations
and recombinant DNA constructs. FastCloning relies on polymerase chain reaction (PCR), to
amplify a desired DNA fragment and target vector sequence such that they can be combined
without utilizing restriction enzymes and ligase to cut and paste constructs. This approach
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introduces a great degree of flexibility into the design of cloning experiments. The key is
designing primers to amplify your target gene, referred to as an insert, to include DNA
“overhangs” complementary to regions of the plasmid on either sides of an engineered cloning
insertion site. The cloning site is created by PCR of the entire plasmid DNA using primers
designed to linearize the once circular plasmid, creating a vector fragment. When these two
PCR products are combined, the complimentary ends on the insert anneal to the vector causing
them to hook together to form a make-shift plasmid, in which the insert and vector fragments
are not ligated together. They are held together by complementary base pairing. The mixture of
vector and insert PCR produces is treated with an enzyme called Dpn1 which digests the
methylated plasmid DNA. Any plasmid used as templates for vector or insert PCR is methylated
during its replication in E. coli. Digesting this methylated DNA reduces carry over parental
plasmid which will reduce the frequency of false-positive clones. After Dpn1 treatment, the
make-shift plasmid is transformed into E. coli, where it is ligated by in vivo DNA repair
mechanisms. Colonies are then selected if they contain the antibiotic resistance gene making
them resistant to an antibiotic in agar plates. Colony PCR will then be utilized for further
sequencing (Figure 3).
Method Protocol:
Fast cloning involves three steps: PCR, fragment assembly/template digestion, and
transformation. Insert and vector fragments were amplified by PCR using Phusion polymerase.
A typical FastCloning PCR reaction will involve the initial use of a template that contains the
genomic sequence that is to be amplified. This template was usually Mtb chromosomal DNA to
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synthesize the insert fragment. A standard reaction mx for the insert PCR would be: 1L of
chromosomal DNA

[17-20 ng/L], 1L forward primer

[10ng/L], 1uL revere primer

[10ng/L], 5ul GC buffer, 0.5l dNTP [10mM], 0.25 l Phusion polymerase, and 16.25 L sterile
water. The reactions were ran with standard Phusion PCR cycling (see table two) with an
extension time of 15 seconds, a calculated annealing temperature using the New England
Biolabs (NEB), Tm calculator: https://www.neb.com/tools-and-resources/interactive-tools/tmcalculator. The extension time and annealing temperature is variable depending on the insert
fragment size, and primer annealing temperature. Extension time is determined as 15 seconds
per kilobase of insert needing to be amplified, whereas the primer annealing temperature is
determined by nucleotide content. For the synthesis of the vector fragment, the reaction is
essentially the same. Instead of using chromosomal DNA as the template, we would use a
plasmid engineered in the lab. Using approximately 15-20 ng/L of the template plasmid, we
amplified the vector using a 1.5 minute extension time for vector fragments as they are usually
six kilobases. 5L of the PCR reaction of both the insert and vector are run on a 1% agarose gel
and stained with GelRed nucleic acid stain. A digital photograph is taken utilizing an ultraviolet
light source and imager to confirm product synthesis.
Fragment assembly and template digestion: After confirmation of product syntheses,
insert and vector products are mixed at various ratios to allow for optimal annealing.
Volumetric ratios of 4:1 (6.4L vector + 1.6L insert), 1:1 (4L vector + 4L insert), and 1:4
(1.6L insert + 6.4L insert) vector: insert is used. FastCloning reactions are treated with Dpn1
at 37⁰C for two hours to digest methylated template plasmid DNA used in initial vector PCR.

28

Eliminating template plasmid DNA reduces false positives caused by template plasmid
transformation. 2L of FastCloning reaction is mixed into 25L of NEB chemically competent
heat shock E. coli. E. coli is plated onto LB agar plates with the antibiotics appropriated for
selection marker. Colonies are then selected from the plate for colony PCR to confirm cloning.
Project Relevance:
The FastCloning method was used to synthesize three out of our total four clones. First,
we cloned the native Mtb whiB7 locus which contains the promoter, the putative MT3290.2
gene upstream of whiB7, and the whiB7 gene itself. These three components make up the
native form of the whiB7 locus. This clone will be referred to as Native-MT+WhiB7. The second
clone eliminated the native whiB7 promoter by amplifying the region of the cassette containing
just MT3290.2 and whiB7. That fragment was cloned in front of the strong constitutively active
hsp60 promoter. This clone will be referred to as hsp60-MT+WhiB7. The third clone contains
only whiB7 cloned downstream of a strong constitutively active promoter and will be referred
to as hsp60-WhiB7. These mutant and recombinant versions of whiB7 were FastCloned into a
shuttle vector called pVVG.2, a derivative of the pVV16 plasmid. pVVG.2 is a vector that
includes a green fluorescent protein (GFP) driven by a constitutively highly active hsp60
promoter.
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Figure 3: Summary of FastCloning method. A) PCR vector B) PCR insert C) Mix in vector to insert D) Digest with Dpn1 E)
Transform into E. coli
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Round the Horn
Another method of cloning that is routinely used in the lab is referred to as Round the
Horn [40]. This method is used to further alter clones synthesized using the above FastCloning
method. This method is particularly useful for creating defined deletions or introducing
insertions to DNA at a particular region of interest. For instance, you have regions A, B, and C in
a vector and you want to delete region B. Primers are designed to be on opposite sides of the
target deletion, in this example region B. Prior to use, primers are phosphorylated to facilitate
the subsequent ligation step. PCR will amplify regions starting with A, and then amplifying
around the plasmid through to region C. This will essentially delete the regions of the plasmid
that are no longer desired for the new vector. Once the vector fragment is amplified, the
phosphorylated blunt ends of the linear vector fragment are ligated to form a plasmid. Once
ligated, the vector is then transformed into E. coli where clones will be grown onto agar plates
and selected for colony PCR.
Method Protocol:
Round the Horn is broken up into four essential steps: primer phosphorylation, PCR,
product ligation, and then transformation and screening. Phosphorylation is done to each
individual primer by utilizing T4 Polynucleotide Kinase (PNK): 37L sterile water, 5L 10x kinase
reaction buffer, 1 µL [50mM] MgSO4, 5L primer at [100 µM], 1 µL [100mM] ATP, and 1 µL T4
PNK for a final volume of 50 µL. Reaction incubation occurs for one hour at 37 ⁰C. Heat
inactivate at 95⁰C for five minutes. PCR utilizing the phosphorylated primers: 1 µL of template
vector at 17-20 ng/µL, 1L phosphorylated forward primer, 1 µL phosphorylated revere primer,
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5 µL GC buffer, 0.5 µL dNTP, 0.25 l Phusion polymerase, and 16.25 µL sterile water. We would
amplify the vector using a 1.5 minute extension time, vector fragments are approximately six
kilobases. 5 µL of the reaction is run on a 1% agarose gel, stained with GelRed. A digital
photograph is taken utilizing an ultraviolet light source and imager to confirm product
synthesis. Product is then treated with Dpn1 to digest template methylated plasmid. Product
ligation using Fast-Link ligase: 1.5 µL 10x Fast-Link ligation buffer, .75 µL [10mM] ATP, 3L
Dpn1-ed PCR product, 8.75 µL sterile water, and 1 µL Fast-Link DNA ligase. The reactions were
incubated at room temperature (25⁰C) for 30 minutes before heat inactivation at 70⁰C for 15
minutes. A portion of this reaction was transformed into NEB heat shock E. coli using the
transformation protocol described in Fastcloning section and plated onto LB agar plates with
the appropriate selection marker. Colonies are then selected from the plate for colony PCR to
confirm cloning.
Project Relevance:
Mutagenesis of the WhiB7 promoter and leader sequences is of particular importance in
order to characterize the cis regulatory elements required for WhiB7 to regulate downstream
genes. Bioinformatics tools have identified WhiB7 binding motifs that can be altered.
Truncating the sequences in between the promoter and the gene itself are expected to alter
WhiB7’s ability to activate promoters, including its own. This will increase our understanding of
how WhiB7 acts to maintain virulence and drug resistance. The Round the Horn method was
used to construct our fourth clone which is a derivative of the Native-MT+WhiB7 clone. This
construct was synthesized to essentially delete the MT3290.2 gene, leaving the WhiB7
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promoter fused to WhiB7 and will be referred to as Native-WhiB7 (Figure 4). This mutant
version of WhiB7 was FastCloned into a shuttle vector pVVG.2.

1

2

3

Figure 4: Summary of the Round the Horn method. 1) Phosphorylated
primers amplify and linearize vector 2) Linear vector is ligated 3)
Ligated product ready for subsequent transformations
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Colony PCR and Sequencing
Method Overview:
The colonies that reside on the agar plate are selected and resuspended into a small
tube of water. Once in the tube, the colony is lysed to form a crude mix of DNA and cellular
debris. The crude lysate is then centrifuged to pellet the debris, and the supernatant is used as
a DNA template for screening PCR.
Method Protocol:
Colony PCR has two essential steps, lysing colonies, and then PCR. Colonies were
selected and resuspended in a microcentrifuge tube containing 20 µL sterile water. The
resuspended colonies were then incubated at 100⁰C for five minutes. The tube was then
centrifuged at 13,000 RPM to pellet cellular debris. Supernatant contains chromosomal and
plasmid DNA, which was used as a template for PCR amplification. We used 1 µL of colony
lysate as template into a 10 µl Phusion PCR using standard PCR reaction conditions that were
utilized in FastCloning method. Primers flanking the insertion site of the vector were used to
amplify the region in-between the primers. 5 µL of the reaction was run on a 1% agarose gel
and stained with GelRed. A photograph was taken to analyze product synthesis in comparison
to a negative control. An increase in size compared to a negative control was deemed a positive
clone for FastCloning. A reduction in size in comparison to a negative control is deemed a
positive clone when making deletions using the Round the Horn method. Once “positive”
clones are confirmed by this method, they are grown in culture of LB broth containing 50 µg/mL
of antibiotic selection marker overnight. Each plasmid construct was purified using an alkaline
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lysis protocol consisting of buffers made in-house coupled with Eco spin purification columns.
Isolated plasmids were then used for sequence analysis, further manipulations, or
transformation.
Sequence analysis
The accurate assembly of recombinant constructs was confirmed by dideoxy sequencing
of plasmids from positive clones at an offsite company. An adapted no cycling, single extension
PCR is done utilizing one specific primer to decode a region of DNA whose sequence needs to
be confirmed. The reaction is done in the presence of dideoxy terminator nucleotides mixed in
with normal nucleotides which will cause synthesis termination at various stages, each
fragment being a single nucleotide bigger than the previous. The products are then run through
a glass capillary gel electrophoresis to separate terminated sequences based on size. That gel
will be exposed to a laser that will cause the dideoxy terminator nucleotides to fluoresce. The
fluorescence is recorded by a computer that analyzes the colors, a different color per base,
based on size. This makes a nucleotide readout that places them in sequential order from the
start of the primer binding, through the mutated sequence of DNA in question [41]. That
sequence data is then compared in silico with the designed genomic DNA for confirmation.
Method Protocol:
Sequencing is done at GENEWIZ, Inc. - DNA Sequencing Services. A reaction of plasmid,
and a sequencing primer is prepared for shipment. A typical reaction for sequencing includes
700-800 ng of plasmid DNA, and 25pM of sequencing primer mixed to a final volume of 15 µL.
Prepared mix is then sent to GENEWIZ. A detailed sequence analysis is retrieved and compared

35

with in silico models of positive clones. Positive clones are confirmed as exact sequence with
hypothesized in silico models.
FastCloning Knockout
Method overview:
The WhiB7 homologue in Msm (WhiB7Msm) could potentially interfere with studies of
WhiB7Mtb function. Thus, knocking out the native WhiB7Msm gene is necessary in order to have
a clean background prior to the introduction of Mtb WhiB7 (WhiB7Mtb). Utilization of the
FastCloning method previously described can be done to synthesize various knockout
constructs to inactivate genes of interest, in this case WhiB7Msm (MSMEG_1953). In this
method, we used a plasmid called pFCKO which stands for
“FastCloning Knockout plasmid”. The pFCKO plasmid contains a
hygromycin

selection

marker

(HYG)

with

flanking

loxP

recombination sites, and an rpsL counterselectable marker. The
knockout procedure involves the amplification of regions
approximately 1 kb upstream and downstream of the target

Figure 5 : pFCKO vector
construct. Green and grey boxes
represent inserted
chromosomal DNA

gene MSMEG_1953, WhiB7Msm, and Fastcloning them onto either
side of a hygromycin (Hyg) selection marker. When this construct crosses into the chromosome
it will delete any region in between them, while adding a hygromycin selection marker. Positive
colonies that have integrated our genetic mutations can then be identified based on resistance
to the hygromycin antibiotic when growing on agar plates. This will allow the introduction of
WhiB7Mtb without interference of WhiB7Msm (figure 5).
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rpsL is a gene coding a wild-type ribosomal protein which confers dominant
streptomycin sensitivity, strepS. This can be used to select bacteria which undergo double
homologous recombination versus single homologous recombination. Single crossover events
will result in integration of the entire pFCKO plasmid including the rpsL cassette onto the
chromosome making the bacterium strepS [11]. A double cross recombinant mutant will
effectively inactivate a target gene, maintain native resistance to streptomycin, while adding a
hygromycin selection marker. Streptomycin and hygromycin resistance will allow us to select
for clones containing a double-cross recombination, and be determined as positive for knocking
out the target gene.
Once the pFCKO has successfully undergone double homologous recombination we will
utilize the loxP sites flanking the HYG marker. A recombinase enzyme called Cre can resolve out
anything between loxP sites. We will transform a plasmid expressing Cre into our ∆WhiB7 hygR
strain of Msm. Doing this will cause the HYG gene to be resolved out of the chromosome. We
will then select for the loss of HYG by plating on agar plates, then moving the colonies to a
hygromycin containing agar plate. Death of colonies after moving them to a Hyg agar plate
would indicate positive colonies. Resolving out the HYG marker using a Cre expressing plasmid
will allow us to utilize HYG as a selection marker for further mutagenic introductions.
Method Protocol:
The pFCKO knockout is done in two stages. The upstream fragment is amplified by PCR
using the standard conditions described above.

It is then cloned into the pFCKO vector and

then transformed into E. coli. Positive clones are verified through colony PCR and sequencing.
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Similarly, the amplified downstream fragment is Fastcloned into the resulting vector on the
other side of the Hyg marker. Once positive clones in E. coli are found to contain both upstream
and downstream fragments using PCR primers to amplify the cloning region of pFCKO, the
pFCKO vector is then electroporated into the target bacterial strain, in this study Msm. The
Msm possibly containing the pFCKO plasmid is plated on hygromycin and streptomycin
containing LB agar plates. Colonies growing on the double antibiotic plates are then selected as
positive for WhiB7Msm knockout, ΔWhiB7Msm.
To remove the hygromycin cassette, a plasmid expressing the Cre recombinase is
transformed by electroporation into the knockout strain followed by plating on LB agar plates.
Colonies on the LB plates are then transferred to a hygromycin LB plate. Death of colony on
hygromycin plate indicates resolution of hygromycin selection marker from positive knockout
strains.
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Figure 6: Summary of FastCloning Knockout method. A) FastClone DNA flanking target gene on either side of HygR marker. B) Electroporate
into Msm. C) Select for double crossover knockout based on HygR and StrepR
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Fluorescent reporter system
Method Overview:
The FastCloning method described above was used to create a fluorescent assay that
can detect promoter activity through the use of a plate reader. Our double-fluorescent reporter
system will be able to detect activation levels of a promoter that can be cloned upstream of a
fluorescent protein called mCherry, and compare it to the basal level activation of another
fluorescent protein called green fluorescent protein (GFP). The mCherry protein is a protein
that can be detected at an excitation of 580nm and an emission at 615nm. This protein is
resistant to photo-bleaching, and is detectible almost immediately after its activation. GFP is a
protein similar to mCherry, immediately detectable, excitation of 475nm and an emission at
508nm, and resistant to photo-bleaching. The system will be designed to have the mCherry
protein integrated to the bacterial chromosome driven by an promoter that is the focus of
current study, and have GFP on an expression plasmid driven by a constitutive hsp60 promoter
that is always active in vivo. When the promoter:mCherry fusion is on the chromosome, and
the GFP on an expression plasmid in the cytoplasm of the same bacterium, the mCherry signal
can be normalized. If a transcription factor known to activate the promoter of the mCherry
reporter is placed on same expression plasmid of the hsp60:GFP, changes in the ratio of
mCherry signal compared to GFP signal can be attributed to the activity of the transcription
factor. High levels of mCherry signal in comparison to GFP signal will provide strong evidence of
transcription factor-promoter communication.
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Construction of WhiB7-activated fluorescent reporter:
Putting the Rv1258 promoter upstream of mCherry will allow mCherry expression to
serve as an indicator of WhiB7Mtb activity. The Rv1258c promoter consisting of 500bp upstream
of the well-characterized Tap efflux pump was Fastcloned into
a shuttle vector called pUAB400. The promoter was inserted
upstream

of

mCherry

and

the

resulting

construct,

Rv1258c:mCherry, was confirmed by sequence analysis to
ensure

proper

placement

of

Rv1258c

(Figure

7).

Rv1258c:mCherry was then transformed into wild-type Msm
Figure 7: pUAB400 containing
Rv1258c reporter

to confirm the activity of the promoter based on detectable
mCherry fluorescence in the plate reader. This vector will be

electroporated into the WhiB7 homologue knockout strain in Msm once that strain is
completed, where it will cross into chromosomal DNA. When WhiB7 becomes activated, the
Rv1258 promoter will cause the transcription of mCherry and synthesis of mCherry which will
be detectable by a plate reader.
Method Protocol:
Synthesizing the promoter-reporter system involves two steps, reporter integration on
the chromosome, and introduction of a plasmid containing the transcription factor and GFP
normalizer. Using the FastCloning method, Rv1258c was cloned into an integrating shuttle
vector called pUAB400 that has the ability to replicate in E. coli and integrate into the
mycobacterial chromosome. Once cloned, the integrating plasmid is electroporated into our
surrogate Msm. pUAB400 contains a bacteriophage gene called Int that integrates the entire
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plasmid onto the chromosome, including a gene located on vector encoding kanamycin
resistance. Positive colonies will be confirmed for growth on kanamycin LB agar plates.
The normalizer will be synthesized using the FastCloning methods that have been previously
described. The GFP protein was FastCloned with its hsp60 promoter into a plasmid called
pVV16 which is a shuttle plasmid that has the ability to replicate in E.coli and mycobacterium.
Positive clones will confer strong fluorescence compared to background detectable by plate
reader, and then electroporated into competent cells of the strain of Msm positive for
mCherry-promoter fusion. The normalizing pVV16 plasmid with GFP built into it, (pVVG.2), will
create ratio between mCherry signal in comparison to GFP signal which is analyzed to
determine interactions of the mutant and recombinant versions of WhiB7 activation of the
Rv1258c promoter.
A culture of Msm containing the integrated promoter reporter fusion and the pVV16G.2
expression plasmid was grown overnight in 5mL cultures of LB broth containing 0.05% tween80.
Cultures were grown until log phase. Cultures are pelleted at 4,300 rpm, and washed in 1mL of
PBS (phosphate buffered saline) containing 0.05% tween80. 100L of the washed culture is
placed in a clear-bottom 96-well plate. Plate reader settings are set to read optical density
(600nM),

mCherry

signal

(Excitation=580nm,

Emission=615nm),

and

GFP

signal

(Excitation=475nm, Emission=508nm). Fluorescent signals are compared in silico.
Project Relevance:
The mutant and recombinant versions WhiB7 were FastCloned the pVVG.2 shuttle
vector. The presence of the GFP in this shuttle vector will provide an internal baseline to
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normalize mCherry signal, driven by the Rv1258c promoter, within the strain of nonpathogenic
Msm. Changes in the mCherry expression, compared to the expression of GFP, will allow us to
characterize the changes in mCherry being caused by WhiB7 activity and not that of other
variables such as bacterial growth phase. ∆WhiB7 strain of Msm that contains the Rv1258c
promoter fusion to mCherry will be referred to as Msm∆ 1258c::mCherry (Figure 8).
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Figure 8: WhiB7 activated reporter system
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Figure 9: Summary of plasmid used.
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Chapter Five: Results
Nonpathogenic Msm surrogate:
ΔwhiB7Msm
The knockout of the WhiB7 homologue in Msm is yet to be completely confirmed as
positive. Recall that this method involves two separate cloning steps: cloning a fragment
upstream of the hygromycin selection marker, and cloning a fragment downstream of the
hygromycin selection maker. Currently we have the downstream fragment cloned into the
pFCKO vector that can be positively identified through colony PCR analysis, data not shown.
Unfortunately the cloning of the upstream fragment into the pFCKO vector is yet to be
complete. It is due to time constraints and “trouble shooting” that have been inhibitory of this
goal currently, but in the future we will complete this goal. Screening with the M13 primers,
lane two shows the pFCKO base plasmid containing no insert, lane three represents the pFCKO
plasmid containing the downstream fragment. Lane one represents the standard one kilo base
GeneRuler ladder.
1258c::mCherry
To generate a fluorescent reporter strain of the nonpathogenic wild type Msm that
could be used to monitor WhiB7 activity, we cloned the Rv1258c promoter upstream of
mCherry. When plated on kanamycin plates, positive colonies were identified based on
resistance to the kanamycin bactericidal agent. Colony PCR screening followed by plate reader
analysis of fluorescence further confirmed that we had successfully cloned the Rv1258c
promoter into pUAB400, and integrated our construct onto the chromosome. Figure ten
represents the pUAB4001258cmCh chromosomal construct as compared to the wild type
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mc2155 strain of Msm. When comparing the fluorescence of the reporter to the wild type strain
of Msm, we can confirm the presence of our reporter on the chromosome (Figure 10).

Fluorescence of Rv1258c:mCherry
reporter
25000

Fluorescence

20000
15000
mCh/OD
10000
5000
0
wt M.smeg

pUABRv1258mCh-Msm

Figure 10: Validation of Rv1258c fluorescent reporter. This graph positively
confirms pUAB400Rv1258mCh integration.
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WhiB7 mutant and recombinant constructs:
All four constructs proposed were confirmed to contain the desirable gene construct
based on size analysis (Figure 11). Plasmid DNA was isolated and then sent to GENEWIZ for
sequencing, which revealed 100% positive alignment with the in silico model of the construct.
Of the four WhiB7 constructs proposed in the methods section, all four have been successfully
cloned and comfirmed by sequenceing using in silico alignments (Figures 12-15). This success
was not met without difficulty. The GFP protein that was thought to be present on the pVVG.2
plasmid was not present as we originally thought; this was due to false positive sizing analysis
and inaccurately reading culture fluorescence screening assay done in experiments previous to
this project. Identification of this issue was recently discovered during plate reader assay
optimization. Circumvention of this issue is currently in the works, and is left as a story for
another time.
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Figure 11: WhiB7 mutant and recombinant constructs
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Native-MT+WhiB7

1

Figure 12: The sequence alignment above represents the Mtb native version of WhiB7. Sequence
alignment is done to represent the comparison of GENEWIZ sequence data, to the in silico model of the
Native-Mt+WhiB7 construct. Blue box: Putative WhiB7 binding site. Red box: The core promoter -10 and
-35 sigA binding region. Orange box: MT3290.2 gene. Green box: whiB7 open reading frame.
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hsp60-MT+WhiB7

Figure 13: This sequence represents the native whiB7 locus with the whiB7 promoter region removed,
then cloned downstream of the constitutively active hsp60 (not shown). Sequence alignment is done to
represent the comparison of GENEWIZ sequence data, to the in silico model of the hsp60-Mt+WhiB7
construct. Orange box: MT3290.2 gene. Green box: whiB7 open reading frame. Sequence analysis
showed incomplete GENEWIZ sequencing to the end of the WhiB7 open reading frame depicted by the
green box extended passed aligned sequences.
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Native-WhiB7

Figure 14: The sequence alignment above represents the Mtb in vivo version of WhiB7 locus with the
MT3290.2 open reading frame removed. Sequence alignment is done to represent the comparison of
GENEWIZ sequence data, to the in silico model of the Native-WhiB7 construct. Blue box: Putative WhiB7
binding site. Red box: -10 and -35 sigA binding region. Green box: whiB7 open reading frame.
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hsp60-WhiB7

Figure 15: The sequence alignment above represents the Mtb in vivo version of WhiB7 open reading
frame cloned downstream of hsp60 (not shown) with the WhiB7 promoter, and MT3290.2 removed.
Sequence alignment is done to represent the comparison of GENEWIZ sequence data, to the in silico
model of the hsp60-WhiB7 construct. Green box: whiB7 open reading frame.
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Fluorescent reporter system: preliminary results
To identify genetic elements required for WhiB7 mediated, we created a series of
recombinant and mutant strains of WhiB7 and cloned them into the pVV16 expression vector.
We then transformed the WhiB7 constructs into the Msm strain containing the 1258c::mCherry
reporter. We then were able to test WhiB7 activity on the known activated Rv1258c promoter
promoting the tap efflux pump. Results are shown in figure 16.

Fluorescence of whiB7 Clones
40000
35000

Fluorescence

30000
25000
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Ratio of mCh:OD
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10000
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0

Figure 16 Fluorescent reporter system. Graph depicts the changes in the levels of fluorescence based on the
four different whiB7 clones.
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Chapter Six: Discussion
Understanding WhiB7’s ability to regulate Mycobacterium tuberculosis’ homeostatic
state during macrophage stress and antibiotic resistance is a system of particular interest when
developing new strategies for drug intervention. Unfortunately not enough data has been
generated to confidently understand the cis regulatory elements required for WhiB7 mediated
gene regulation. Due to incompletion of the ΔWhiB7Msm 1258c::mCherry model, the WhiB7
clones were instead transformed into the mc2155 strain of Msm. Due to the lack of GFP to act
as a normalizer we instead utilized ocular density of cultures to normalize the mCherry signal.
Although this is not the ideal set up we proposed, we have found expression of the reporter
when exposed to our WhiB7 clones.
The Native-MT+WhiB7 recombinant construct was shown to have the most activity on
the Rv1258 reporter compared to any of the constructs. When we compare the NativeMT+WhiB7construct to the hsp60-MT+WhiB7 construct, we see reduced activity on the
reporter. Due to the elimination of the WhiB7 promoting region, we also eliminated the
possibility of the positive feedback activity of WhiB7, disabling the autoregulatory ability of
WhiB7. This leads us to assume the reduction of reporter fluorescence of hsp60-MT+WhiB7 as
compared to the Native-Mt+WhiB7 clone is caused by disabling this autoregulatory ability.
Recall the function of MT3290.2 has not yet been determined, but data suggests it plays
a role in whiB7 regulation. The Native-WhiB7 mutant in comparison to the Native-MT-WhiB7
clone suggests the deletion of MT3290.2 from the native gene locus has caused a reduction in
WhiB7 activity. This data may suggest that the deletion of this region results in poor whiB7
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regulation, which may be attributed to deletion of a required element. Further data and
analysis will be required to confidently confirm MT3290.2’s role in whiB7 regulation.
The level of fluorescence of the pUAB4001258cmCh Msm control is relatively high in
comparison to the wild type Msm strain. This suggests that the native Msm whiB7 is likely
interacting with the Rv1258c promoter and reaffirms the necessity of the Msm WhiB7 homolog
knockout (ΔWhiB7Msm) to reduce the level of background fluorescence when we introduce our
WhiB7Mtb constructs. When comparing the activity of the Native-WhiB7 and the hsp60-WhiB7
recombinant constructs, we see a reduction in the level of fluorescence. But, due to the lack of
the ΔWhiB7Msm, we cannot deduce any phenotypic generalizations when the levels are below
that of the control pUAB4001258cmch Msm.

56

Chapter Seven: Future works
Due to the issue of time constraints, and unforeseen issues that were previously
described, we were unable to fully address the goal of identifying promoters related to WhiB7
regulation using our promoter reporter system. Genes potentially activated by WhiB7 were
identified by microarray analysis as genes with higher expression levels in a WhiB7
overexpressor strain, and lower expression in the WhiB7 knockout strain.
These studies identified 12 genes that were regulated by WhiB7, but these have yet to
be cloned. In the future, the identified promoters driving these genes will be fused to the
mCherry fluorescent protein in the same fashion described in promoter fusion method in
objective one. Once the promoter fusion is in the chromosomal integration vector, pUAB400, it
will be transformed into the ΔWhiB7Msm as described in objective one. Expression of the
promoter fusion will be regulated by the native WhiB7Mtb if the promoter proves to be in the
WhiB7 regulon. Inducing promoter mCherry expression will correlate with WhiB7Mtb activated
transcription of the promoter, linking the promoters function with WhiB7. Characterization will
be done by comparing the expression levels of the promoter fusion via plate reader assay
analysis. In the future, we hope to clone these promoters into the pUAB400 vector upstream of
mCherry to identify WhiB7 communication.
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Chapter eight: Summary
Creating a strain of nonpathogenic Msm to act as a surrogate for the introduction of
Mtb genes for expression studies will allow us to isolate and characterize WhiB7’s ability to
activate promoters responsible for drug resistance and macrophage survival. Introducing the
native WhiB7 and truncated series of WhiB7 into the Rv1258c reporter knockout strain of Msm
will allow us to define the essential elements required by WhiB7 to maintain full functionality in
its role in the activation of downstream promoters. Confirming additional genes identified by
microarray analysis that are potentially regulated by WhiB7 will provide additional information
about the role of WhiB7. Understanding WhiB7’s ability to regulate Mycobacterium
tuberculosis’ homeostatic state during macrophage stress and antibiotic resistance is a system
of particular interest when developing new strategies for drug intervention.
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